JENNIFER GRACE KWAN-MORLEY MD
NPI 1285799379
Internal Medicine - Rheumatology in Malvern, PA

Active since December 27, 2006
81/100
CMS Quality Rating
266 LANCASTER AVE, SUITE 200, MALVERN, PA 19355(610) 644-6900(610) 644-7160 Get Directions Write a Review

NPPES record last updated: July 18, 2013. Verified against the NPPES registry weekly; last sync: July 26, 2026.

About Jennifer Grace Kwan-morley Md NPPES

Official registry information on file with the National Plan and Provider Enumeration System.

JENNIFER GRACE KWAN-MORLEY MD (NPI 1285799379) is an individual rheumatology provider in Malvern, Pennsylvania, licensed in Pennsylvania (MD427292) and active in the NPI registry since December 2006.

NPPES Registry Identity

NPI1285799379
Entity TypeIndividualFemale
Primary Taxonomy207RR0500X
Provider Legal NameJENNIFER GRACE KWAN-MORLEYCredential: MD
Location Address266 LANCASTER AVE, SUITE 200Malvern, PA 19355-3256
Mailing Address266 Lancaster Ave, Suite 200Malvern, PA 19355-3256 · (610) 644-6900 · Fax (610) 644-7160
Fax(610) 644-7160
Sole ProprietorNo
Enumeration DateDecember 27, 2006
Last NPPES UpdateJuly 18, 2013
NPI 1285799379 is a valid, active identifier and passes the ISO check-digit test.

Specialties & Licenses

Primary SpecialtyInternal Medicine · RheumatologyAllopathic & Osteopathic Physicians
Taxonomy Code207RR0500X
Licenses Licensed in PA · MD427292 Licensed in PA · MT186705
Definition

An internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and collagen diseases.

266 LANCASTER AVE, Malvern, PA 19355

Other Identifiers 2

Medicare UPINI08442
Medicare PIN034967PA

Areas of Expertise CMS Part B claims 21

Services this provider delivered to Medicare fee-for-service patients, from the CMS Medicare utilization data. Higher counts generally reflect more experience with a service; care delivered outside Medicare is not included.

Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) J0717
Certolizumab pegol is a medication injected under a doctor's supervision. It's used to treat certain inflammatory conditions like rheumatoid arthritis. The injection helps reduce symptoms like pain and swelling. Note that this drug isn't for self-administration.
28,000 services12 patients
Injection, denosumab, 1 mg J0897
Denosumab is a medication given via injection to strengthen your bones. It works by slowing down the cells that break down bone, improving bone density and reducing the risk of fractures. It's often used for osteoporosis treatment.
22,560 services247 patients
Injection, golimumab, 1 mg, for intravenous use J1602
Golimumab is a medication given through an IV (a small tube in your vein). It helps to reduce inflammation and pain by blocking a protein in your body that causes inflammation. It's often used to treat conditions like rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.
15,383 services25 patients
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) J0129
Abatacept is a medication administered via injection under a doctor's supervision. It's used to treat conditions like rheumatoid arthritis by moderating the immune system. This code applies when the doctor administers the drug, not for self-administration.
8,275 services24 patients
Injection, rituximab, 10 mg J9312
Rituximab is a medication given via injection. It's used to treat certain types of cancer and autoimmune diseases. The 10 mg dosage refers to the amount of the drug in the injection. It works by targeting and destroying specific cells, helping your body's immune system.
3,050 services14 patients
Injection, infliximab, excludes biosimilar, 10 mg J1745
Infliximab is a medication given via injection to treat certain autoimmune conditions. It works by blocking the action of a substance in your body that causes inflammation. Each dose is based on your medical condition and response to treatment.
2,670 services12 patients

Medicare Quality Performance CMS QPP · MIPS

Performance in the CMS Quality Payment Program: the MIPS final score across four weighted categories, and the individual quality measures reported to Medicare.

81/100
MIPS Final ScoreMerit-based Incentive Payment System · CMS Quality Payment Program
Individually scored
Quality77.65
Improvement Activities40

Reported Quality Measures

Appropriate Treatment for Upper Respiratory Infection (URI)
94%99 patients4/55-star benchmark: 100%
Colorectal Cancer Screening
1%1,204 patients1/55-star benchmark: 88%
Controlling High Blood Pressure
71%174 patients4/55-star benchmark: 91%
Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%)
Lower rates are better for this measure.
81%64 patients1/55-star benchmark: 91%
Documentation of Current Medications in the Medical Record
97%2,957 patients4/55-star benchmark: 100%
Falls: Screening for Future Fall Risk
48%1,097 patients2/55-star benchmark: 100%
Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented
34%1,960 patients3/55-star benchmark: 61%
Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
Patients combinedPopulations: 72% · 1,453 patients
Patients screened: 73% · 1,453 patients
76%33 patients4/55-star benchmark: 100%
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease
82%426 patients4/55-star benchmark: 91%
Use of High-Risk Medications in Older Adults
Lower rates are better for this measure.
Patients appropriateDiagnosis: 1% · 1,148 patients
Patients totalRate: 2% · 1,148 patients
2%1,148 patients4/55-star benchmark: 100%
Providers report different measures because they deliver different services; reporting more or less information is not a reflection of quality. Star ratings appear only where CMS assigned them.

Other Providers at the Same Location NPPES 20

Providers registered at the same practice address, or within the immediate area, according to the NPPES registry.

Internal Medicine
266 LANCASTER AVE, SUITE 301
MALVERN, PA 19355
Physical Therapist
266 LANCASTER AVE, SUITE 200
MALVERN, PA 19355
Physical Therapist (Orthopedic)
266 LANCASTER AVE
MALVERN, PA 19355
Specialist
266 LANCASTER AVE, SUITE 200
MALVERN, PA 19355
Specialist
266 LANCASTER AVE, SUITE 200
MALVERN, PA 19355
Podiatrist (Foot & Ankle Surgery)
266 LANCASTER AVE, SUITE 200
MALVERN, PA 19355
Orthopaedic Surgery
266 LANCASTER AVE, SUITE 200
MALVERN, PA 19355
Specialist
266 LANCASTER AVE, SUITE 200
MALVERN, PA 19355

Frequently Asked Questions NPPES & CMS

Common questions about this NPI record, answered from the official NPPES registry and CMS datasets shown on this page.

What is Jennifer Kwan-morley's NPI number?

The NPI number for Jennifer Kwan-morley is 1285799379. It was assigned to this individual provider in the NPPES registry on December 27, 2006.

Where is Jennifer Kwan-morley located?

Jennifer Kwan-morley practices at 266 Lancaster Ave Suite 200, Malvern, PA 19355. The listed phone number is (610) 644-6900.

What is Jennifer Kwan-morley's specialty?

The primary specialty registered for this NPI is Internal Medicine, specializing in Rheumatology, with taxonomy code 207RR0500X.

When was this NPI record last updated?

The NPPES record for Jennifer Kwan-morley was last updated on July 18, 2013. NPI Profile syncs with the weekly NPPES data releases published by CMS.